Literature DB >> 35616749

ASO Author Reflections: A Novel Mechanism of Suppressing Proliferation After Inhibition of Clusterin in Pancreatic Cancer.

Suguru Mitsufuji1, Yoshifumi Iwagami1, Shogo Kobayashi2, Kazuki Sasaki1, Daisaku Yamada1, Yoshito Tomimaru1, Hirofumi Akita1, Tadafumi Asaoka1, Takehiro Noda1, Kunihito Gotoh1, Hidenori Takahashi1, Masahiro Tanemura1, Yuichiro Doki1, Hidetoshi Eguchi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35616749     DOI： 10.1245/s10434-022-11745-4

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  5 in total

1.  Clusterin inhibits apoptosis by interacting with activated Bax.

Authors:  Honglai Zhang; Jin Koo Kim; Chris A Edwards; Zhaohui Xu; Russell Taichman; Cun-Yu Wang
Journal:  Nat Cell Biol       Date:  2005-08-21       Impact factor: 28.824

2.  Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, international, phase 3 trial.

Authors:  Tomasz M Beer; Sebastien J Hotte; Fred Saad; Boris Alekseev; Vsevolod Matveev; Aude Fléchon; Gwenaelle Gravis; Florence Joly; Kim N Chi; Zafar Malik; Brent Blumenstein; Patricia S Stewart; Cindy A Jacobs; Karim Fizazi
Journal:  Lancet Oncol       Date:  2017-10-09       Impact factor: 41.316

3.  Phase I/II trial of custirsen (OGX-011), an inhibitor of clusterin, in combination with a gemcitabine and platinum regimen in patients with previously untreated advanced non-small cell lung cancer.

Authors:  Janessa J Laskin; Garth Nicholas; Christopher Lee; Barbara Gitlitz; Mark Vincent; Yvon Cormier; Joe Stephenson; Yee Ung; Rachel Sanborn; Bryn Pressnail; Francis Nugent; John Nemunaitis; Martin E Gleave; Nevin Murray; Desiree Hao
Journal:  J Thorac Oncol       Date:  2012-03       Impact factor: 15.609

4.  ASO Author Reflections: A Novel Mechanism of Suppressing Proliferation After Inhibition of Clusterin in Pancreatic Cancer.

Authors:  Suguru Mitsufuji; Yoshifumi Iwagami; Shogo Kobayashi; Kazuki Sasaki; Daisaku Yamada; Yoshito Tomimaru; Hirofumi Akita; Tadafumi Asaoka; Takehiro Noda; Kunihito Gotoh; Hidenori Takahashi; Masahiro Tanemura; Yuichiro Doki; Hidetoshi Eguchi
Journal:  Ann Surg Oncol       Date:  2022-05-26       Impact factor: 5.344

Review 5.  Pancreatic Cancer and Therapy: Role and Regulation of Cancer Stem Cells.

Authors:  Susmita Barman; Iram Fatima; Amar B Singh; Punita Dhawan
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923
  5 in total
  1 in total

1.  ASO Author Reflections: A Novel Mechanism of Suppressing Proliferation After Inhibition of Clusterin in Pancreatic Cancer.

Authors:  Suguru Mitsufuji; Yoshifumi Iwagami; Shogo Kobayashi; Kazuki Sasaki; Daisaku Yamada; Yoshito Tomimaru; Hirofumi Akita; Tadafumi Asaoka; Takehiro Noda; Kunihito Gotoh; Hidenori Takahashi; Masahiro Tanemura; Yuichiro Doki; Hidetoshi Eguchi
Journal:  Ann Surg Oncol       Date:  2022-05-26       Impact factor: 5.344
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.